慢性胰腺炎中西医结合诊疗共识意见(2020)

2020-10-12 中国中西医结合学会消化系统疾病专业委员会 中国中西医结合消化杂志.2020.28(10):731-739.

慢性胰腺炎(CP)是各种病因引起胰腺组织形态和功能不可逆性改变的慢性迁延性炎症性疾病,其疼痛、腹泻等症状顽固,需终身替代治疗,影响患者生活质量,加重个人、家庭、社会的经济负担。近年来,随着社会经济水平

中文标题:

慢性胰腺炎中西医结合诊疗共识意见(2020)

发布日期:

2020-10-12

简要介绍:

慢性胰腺炎(CP)是各种病因引起胰腺组织形态和功能不可逆性改变的慢性迁延性炎症性疾病,其疼痛、腹泻等症状顽固,需终身替代治疗,影响患者生活质量,加重个人、家庭、社会的经济负担。近年来,随着社会经济水平的提高和饮食结构的变化,CP发病率在全球不断上升,病因病机、分期分阶段、诊断标准和中西医结合治疗药物与新手段迭出,中医药辨证论治分期分型治疗报道不断增加,国际国内临床诊疗指南不断更新。中国中西医结合学会消化系统疾病专业委员会牵头组织国内中、西医消化学界多学科专家,依据最新循证医学证据和国内外最新研究结果,就CP的定义、诊断、分期、中医分型、辨证治疗、中西医结合诊治要点等问题进行讨论,按照德尔斐法进行了3轮次投票,通过了《慢性胰腺炎中西医结合诊疗共识意见》.

相关资料下载:
[AttachmentFileName(sort=1, fileName=慢性胰腺炎中西医结合诊疗共识意见_2020_唐文富.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e08491c002005ab4, title=慢性胰腺炎中西医结合诊疗共识意见(2020) , enTitle=, guiderFrom=中国中西医结合消化杂志.2020.28(10):731-739., authorId=0, author=, summary=慢性胰腺炎(CP)是各种病因引起胰腺组织形态和功能不可逆性改变的慢性迁延性炎症性疾病,其疼痛、腹泻等症状顽固,需终身替代治疗,影响患者生活质量,加重个人、家庭、社会的经济负担。近年来,随着社会经济水平, cover=https://img.medsci.cn/20201031/1604155974602_2020535.jpg, journalId=0, articlesId=null, associationId=106, associationName=中国中西医结合学会消化系统疾病专业委员会, associationIntro=中国中西医结合学会:China Society of Integrated Traditional Chinese and Western Medicine   中国中西医结合工作者的群众性学术团体。宗旨是团结全国中西医结合工作者开展学术活动,以促进中西医结合科学技术的发展与推广,培养科技人才,为形成具有中国特色的医药学做出贡献。   成立于1981年11月,原称中国中西医结合研究会,1990年改为中国中西医结合学会。现有会员 27000余名。拥有部分外籍(美国、日本等国家和地区)通讯会员。季钟朴、崔月犁、吴咸中分别为第一、二、三届理事长。 理事会下设学术、组织、科普及宣传、编辑、咨询、国际学术交流及联络、教育等七个工作委员会。所属二级学术组织有急腹症、活血化瘀、肿瘤、骨伤科、妇产科、儿科、眼科、耳鼻喉科、呼吸病、 精神疾病、 肝病、周围血管疾病、皮肤性病、风湿类疾病、血液病、心血管疾病、虚证与老年病、消化系统疾病、 急救医学、 医学影像学、基础理论研究、四诊研究、微循环、中药、疮疡、农村基层、管理等27个专业委员会。在全国(除台湾省外)30个省、自治区、直辖市及部分地、市、县设有分会。学会的主要任务是组织学术交流,编辑出版学术刊物,推广科技成果,普及中西医结合医学知识,培养中西医结合人才等。学会主办刊物《中西医结合杂志》(月刊)创刊于1981年,现已发行至全国及世界50多个国家和地区。, copyright=0, guiderPublishedTime=Mon Oct 12 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>慢性胰腺炎(CP)是各种病因引起胰腺组织形态和功能不可逆性改变的慢性迁延性炎症性疾病,其疼痛、腹泻等症状顽固,需终身替代治疗,影响患者生活质量,加重个人、家庭、社会的经济负担。近年来,随着社会经济水平的提高和饮食结构的变化,CP发病率在全球不断上升,病因病机、分期分阶段、诊断标准和中西医结合治疗药物与新手段迭出,中医药辨证论治分期分型治疗报道不断增加,国际国内临床诊疗指南不断更新。中国中西医结合学会消化系统疾病专业委员会牵头组织国内中、西医消化学界多学科专家,依据最新循证医学证据和国内外最新研究结果,就CP的定义、诊断、分期、中医分型、辨证治疗、中西医结合诊治要点等问题进行讨论,按照德尔斐法进行了3轮次投票,通过了《慢性胰腺炎中西医结合诊疗共识意见》.</p> </div> </div> </div>, tagList=[TagDto(tagId=14127, tagName=慢性胰腺炎)], categoryList=[CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=14127, guiderKeyword=慢性胰腺炎, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3155, appHits=270, showAppHits=0, pcHits=717, showPcHits=2884, likes=2, shares=24, comments=4, approvalStatus=1, publishedTime=Sat Oct 31 23:09:01 CST 2020, publishedTimeString=2020-10-12, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sat Oct 31 22:53:02 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:21:54 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=慢性胰腺炎中西医结合诊疗共识意见_2020_唐文富.pdf)])
慢性胰腺炎中西医结合诊疗共识意见_2020_唐文富.pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1003067, encodeId=90cf100306e61, content=写的非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:02:56 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947624, encodeId=954494e6243b, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:20:07 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947621, encodeId=5a9894e621b8, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:19:11 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915989, encodeId=40809159891d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efc13053194, createdName=1372a1226cm, createdTime=Tue Jan 12 19:02:33 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-07-27 1e1606abm78(暂无匿称)

    写的非常好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1003067, encodeId=90cf100306e61, content=写的非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:02:56 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947624, encodeId=954494e6243b, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:20:07 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947621, encodeId=5a9894e621b8, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:19:11 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915989, encodeId=40809159891d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efc13053194, createdName=1372a1226cm, createdTime=Tue Jan 12 19:02:33 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-03-12 ms2092437969606777

    已看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1003067, encodeId=90cf100306e61, content=写的非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:02:56 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947624, encodeId=954494e6243b, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:20:07 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947621, encodeId=5a9894e621b8, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:19:11 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915989, encodeId=40809159891d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efc13053194, createdName=1372a1226cm, createdTime=Tue Jan 12 19:02:33 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-03-12 ms2092437969606777

    已看

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1003067, encodeId=90cf100306e61, content=写的非常好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:02:56 CST 2021, time=2021-07-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947624, encodeId=954494e6243b, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:20:07 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=947621, encodeId=5a9894e621b8, content=已看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/5u9ibEU2pUTF2ewf8n4QibHPtyf0cWUvbgicEhhFQmKUrfaFb5BcQLXjl6onDD128kE3kmibjicG0qKr4fb2eoIBQdw/132, createdBy=ae892328624, createdName=ms2092437969606777, createdTime=Fri Mar 12 11:19:11 CST 2021, time=2021-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915989, encodeId=40809159891d, content=好文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=efc13053194, createdName=1372a1226cm, createdTime=Tue Jan 12 19:02:33 CST 2021, time=2021-01-12, status=1, ipAttribution=)]
    2021-01-12 1372a1226cm

    好文

    0

拓展阅读

2015年JSGE循证临床实践指南:慢性胰腺炎

日本胃肠病学会(JSGE,Japanese Society of Gastroenterology) · 2016-06-08

2018 IAP/APA/JPS/EPC指南:慢性胰腺炎截面影像学诊断和严重程度评分

国际胰腺病协会(IAP,International Association of Pancreatology) · 2018-08-28

2018 ESGE指南:慢性胰腺炎的内镜治疗

欧洲胃肠道内窥镜学会(ESGE,European Society of Gastrointestinal Endoscopy) · 2019-01-17

消化系统常见病慢性胰腺炎中医诊疗指南(基层医生版)

中华中医药学会外科分会 · 2019-12-26